Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06853964 · ClinicalTrials.gov registry record
Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction
A clinical trial of Pre-Pectoral Breast Reconstruction Following Mastectomy, sponsored by AlloSource.
- Active
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06853964: Active study of Pre-Pectoral Breast Reconstruction Following Mastectomy, sponsored by AlloSource.
NCT06853964 is a study of Pre-Pectoral Breast Reconstruction Following Mastectomy that is active but no longer recruiting, run by AlloSource. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06853964, a study of Pre-Pectoral Breast Reconstruction Following Mastectomy, is active but no longer recruiting, sponsored by AlloSource.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This retrospective, single-site study will provide information regarding the efficiency of AlloMend® Acellular Dermal Matrix allograft in Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.
Primary Outcome
This primary outcome measure will retrospectively collect descriptive data on patients who have undergone single or double mastectomy followed by pre-pectoral breast reconstruction using AlloMend® Acellular Dermal Matrix allograft. Data will be extracted from medical records and will include patient demographics, medical history, surgical techniques, intraoperative and postoperative complications, prescribed medications, and adjuvant treatments such as chemotherapy and radiation. The objective i
Conditions Studied
Interventions
- OTHER AlloMend® Acellular Dermal Matrix allograft
Study Locations (1)
Nevada
- Janiga MDs Plastic Surgery and Cosmetic Center - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2026-05-31 |
What the registry record for NCT06853964 still lists
NCT06853964 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pre-Pectoral Breast Reconstruction Following Mastectomy appearing as the primary indexed condition, and to 1 intervention - of which AlloMend® Acellular Dermal Matrix allograft is the first listed.
NCT06853964 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT06853964 about?
NCT06853964 is a clinical study titled "Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction". This retrospective, single-site study will provide information regarding the efficiency of AlloMend® Acellular Dermal Matrix allograft in Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.
What is the current status of trial NCT06853964?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2025-01-27. Estimated completion is 2026-05-31.
What conditions does trial NCT06853964 study?
This clinical trial studies the following conditions: Pre-Pectoral Breast Reconstruction Following Mastectomy.
What interventions are being tested in trial NCT06853964?
The interventions under investigation include: AlloMend® Acellular Dermal Matrix allograft (OTHER).
Who is sponsoring clinical trial NCT06853964?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06853964 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI